← All devices 
Clinical / medical-grade · Patch / sensor · by Medtronic
Medtronic Simplera
A disposable, fingerstick-free CGM that feeds Medtronic’s automated insulin delivery — FDA-approved, prescription, Medtronic-controlled.
August 2024Medtronic Simplera
Mid-cycle1 yr 10 mo old
Simplera Sync for the MiniMed 780G was FDA-approved in April 2025.
API access: Yes — restricted Raw data access: Yes — restricted Open source: Community
Clinical value
84/100
FDA-approved, AID-integrated CGM
Empowerment
58/100
Clinician portal, Rx, closed ecosystem
Everyday value
54/100
Half-size disposable sensor
A disposable, all-in-one continuous glucose monitor about half the size of Medtronic’s prior sensors, with no fingersticks, that feeds the MiniMed 780G automated insulin-delivery system — FDA-approved and prescription-only, inside a Medtronic-controlled ecosystem.
What it measures
Continuous interstitial glucose every 5 minutes from a disposable body-worn sensor; Simplera Sync drives the MiniMed 780G closed loop, while standalone Simplera pairs with the InPen smart insulin pen.
Regulatory status
FDA-approved in the US — Simplera CGM (Aug 2024) and Simplera Sync for the 780G (Apr 2025). Prescription-only; CE-marked in Europe. The prior Guardian 4 sensor is also FDA-cleared.
Validation & accuracy
Pivotal trial data on file (ages 2–80); reported MARD ~10.2%, with weaker accuracy in the first ~12 hours of wear relative to Dexcom G7 and FreeStyle Libre 3.
Data control & export
Raw data: restricted — Medtronic apps plus the CareLink clinician portal for sharing and AGP/PDF reports. API: restricted — a Medtronic-controlled, exclusive-integration ecosystem with limited open third-party access.
Wearability & battery
A disposable, all-in-one sensor about half the size of prior Medtronic CGMs, with two-step insertion and no fingersticks; replaced roughly weekly.
Cost & access
Prescription required; typically billed through pharmacy/DME and covered by insurance/Medicare for insulin-using diabetes. Recurring sensor resupply cost; no subscription.
Who it serves
People with diabetes on Medtronic automated insulin delivery (MiniMed 780G) or smart MDI who want a smaller, fingerstick-free sensor.
Who is left out or burdened
Prescription and payer authorization required; locked to the Medtronic ecosystem; weaker early-wear accuracy; recurring resupply cost.
✓ Strengths
- FDA-approved CGM; integrates with the MiniMed 780G closed loop
- Disposable, all-in-one sensor about half the prior size
- No fingersticks with SmartGuard
- CareLink clinician sharing and AGP reports
✕ Weaknesses
- Prescription-only; payer authorization required
- Locked to the Medtronic ecosystem; limited open API
- Weaker accuracy in the first ~12 hours of wear
- Recurring sensor resupply cost
84
Why this clinical score. An FDA-approved, AID-integrated CGM with no fingersticks is clinically top-tier; a ~10.2% MARD and softer warm-up keep it just below Dexcom and Libre.
58
Why this empowerment score. Clinician-portal sharing and cloud reports help, but prescription gatekeeping and a closed, Medtronic-controlled ecosystem with limited open access cap empowerment mid-range.
54
Why this everyday score. Comfortable, half-size, and fingerstick-free, but single-purpose with weekly sensor changes and an ongoing resupply.
Latest news
Reviews & coverage
Coverage frames Simplera as Medtronic's simpler, disposable all-in-one CGM aimed at closing the gap with Dexcom/Libre. Reviewers are watching real-world accuracy and integration with Medtronic's automated insulin systems.
Summary is a draft synthesis of public coverage, not an endorsement. Links open a search of each outlet.
Reddit communities
Independent user communities where this device (or its category) is discussed.
Get it · manuals & support
Draft profile · public-source review, June 2026 · scores describe direction and degree, not buying advice. News, links, and prices change — verify with the manufacturer. Image is representative.